| Literature DB >> 30274919 |
K Bunaux1, H Sevestre2, J-F Emile3, C Capel4, L Chenin4, J Peltier4.
Abstract
Erdheim-Chester disease is a rare form of non-Langerhans cell histiocytosis. It is an inflammatory disorder associated with BRAF V600E mutation in 50% of cases. This multisystem disease is rarely associated with spinal involvement. Neurological involvement is an independent predictive factor of poor prognosis. The diagnosis is histopathological based on CD68-positive and CD1A-negative histiocytes. Treatment with interferon-alpha is an independent predictor of survival in Erdheim-Chester disease and vemurafenib has also been shown to be effective for BRAF V600E mutation. We report a clinical case of a 51-year-old patient with multiple and rare locations of Erdheim-Chester disease, particularly at the sphenoid sinus.Entities:
Keywords: Erdheim-Chester disease; Non-Langerhans cell histiocytosis; Sphenoid sinus involvement; Spinal cord compression
Mesh:
Substances:
Year: 2018 PMID: 30274919 DOI: 10.1016/j.neuchi.2018.08.002
Source DB: PubMed Journal: Neurochirurgie ISSN: 0028-3770 Impact factor: 1.553